Drug
Ganciclovir (GCV)
Ganciclovir (GCV) is a pharmaceutical drug with 5 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
5
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
1(20%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_2
2
40%
Ph not_applicable
2
40%
Ph phase_1
1
20%
Phase Distribution
1
Early Stage
2
Mid Stage
0
Late Stage
Phase Distribution5 total trials
Phase 1Safety & dosage
1(20.0%)
Phase 2Efficacy & side effects
2(40.0%)
N/ANon-phased studies
2(40.0%)
Highest Phase Reached
Phase 2Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
5
all time
Status Distribution
Active(2)
Completed(2)
Other(1)
Detailed Status
Completed2
Not yet recruiting1
unknown1
Recruiting1
Development Timeline
Analytics
Development Status
Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 2
Trials by Phase
Phase 11 (20.0%)
Phase 22 (40.0%)
N/A2 (40.0%)
Trials by Status
completed240%
not_yet_recruiting120%
unknown120%
recruiting120%
Recent Activity
1 active trials
Showing 5 of 5
recruitingphase_2
Study Evaluating the Efficacy and Safety of Artesunate
NCT06853184
not_yet_recruitingphase_2
Efficacy and Safety of Low-dose IL-2 in SLE Patients With CMV Viremia
NCT06971913
completednot_applicable
Topical Ganciclovir Versus Systemic Aciclovir in the Treatment of Herpetic Keratitis
NCT06757907
unknownnot_applicable
Femtosecond Laser-assisted Corneal Debridement for Herpes Simplex Keratitis
NCT03217474
completedphase_1
A Study of an Infectivity Enhanced Suicide Gene Expressing Adenovirus for Ovarian Cancer in Patients With Recurrent Ovarian and Other Selected Gynecologic Cancers
NCT00964756
Clinical Trials (5)
Showing 5 of 5 trials
NCT06853184Phase 2
Study Evaluating the Efficacy and Safety of Artesunate
NCT06971913Phase 2
Efficacy and Safety of Low-dose IL-2 in SLE Patients With CMV Viremia
NCT06757907Not Applicable
Topical Ganciclovir Versus Systemic Aciclovir in the Treatment of Herpetic Keratitis
NCT03217474Not Applicable
Femtosecond Laser-assisted Corneal Debridement for Herpes Simplex Keratitis
NCT00964756Phase 1
A Study of an Infectivity Enhanced Suicide Gene Expressing Adenovirus for Ovarian Cancer in Patients With Recurrent Ovarian and Other Selected Gynecologic Cancers
All 5 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 5